FDA Monthly Preview: Key June Decisions to Watch

• by Kathryn Wighton

• May 29, 2026

Comment on: Changes in microbiological characteristics of bloodstream infections before and after the COVID-19 pandemic in a tertiary teaching hospital in Iran

• by Sebastiana Silva Sabino, Alexia Máximo Fernandes, Natália Ludendorff Queiroz, Cristiane Silveira de Brito, Lícia Ludendorff Queiroz, Celsa Raquel Villaverde Melgarejo, Paulo P. Gontijo Filho, Rosineide Marques Ribas

• September 16, 2026

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

• by Kathryn Wighton

• August 28, 2026

• 2 min

CDC recommends 2026–2027 COVID vaccines for all adults

Updated guidance recommends vaccination for adults aged 18 years and older, with pediatric recommendations based on immune status.

• by Teraya Smith

• October 9, 2026

• 3 min